Loading…
Based on limited metadata from an FDA Warning Letter issued to United Pharmacy on February 11, 2019, the agency identified compliance concerns related to drug products. Without access to the full letter text or specific subject line details, the precise nature of the violations cannot be determined, though they likely involved manufacturing, quality control, or distribution practices for pharmaceutical products. The warning was issued under FDA's drug regulation authority, though the specific issuing office is not identified in the available metadata. Additional documentation would be needed to understand the complete scope and specific requirements for corrective action.